{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:35:17Z","timestamp":1791412517590,"version":"4.3.3"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejogrb.2024.09.040","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T16:27:59Z","timestamp":1727454479000},"page":"310-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Maintenance pharmacological therapy of recurrent vulvovaginal candidiasis. A Bayesian network meta-analysis of randomized studies"],"prefix":"10.1016","volume":"302","author":[{"given":"Barbara","family":"Gardella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6322-607X","authenticated-orcid":false,"given":"Mattia","family":"Dominoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna Francesca","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsenio","family":"Spinillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2024.09.040_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.934353","article-title":"Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion","volume":"12","author":"Donders","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.09.040_b0010","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12905-022-01973-x","article-title":"Lived experience of medical management in recurrent vulvovaginal candidiasis: a qualitative study of an uncertain journey","volume":"22","author":"Bradfield Strydom","year":"2022","journal-title":"BMC Womens Health"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.09.040_b0015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/myc.13248","article-title":"Guideline: Vulvovaginal candidosis (AWMF 015\/072, level S2k)","volume":"64","author":"Farr","year":"2021","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.09.040_b0020","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1093\/cid\/ciab1057","article-title":"Vulvovaginal candidiasis: a review of the evidence for the 2021 centers for disease control and prevention of sexually transmitted infections treatment guidelines","volume":"74","author":"Nyirjesy","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.09.040_b0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1472-6874-14-43","article-title":"Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented","volume":"14","author":"Rathod","year":"2014","journal-title":"BMC Womens Health"},{"issue":"11","key":"10.1016\/j.ejogrb.2024.09.040_b0030","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1016\/S1473-3099(18)30103-8","article-title":"Global burden of recurrent vulvovaginal candidiasis: a systematic review","volume":"18","author":"Denning","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.09.040_b0035","first-page":"38","article-title":"Topical treatment of recurrent vulvovaginal candidiasis: an expert consensus","volume":"3","author":"Phillips","year":"2022","journal-title":"Womens Health Rep (New Rochelle)"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.09.040_b0040","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1080\/00273171.2022.2115965","article-title":"A gentle introduction to Bayesian network meta-analysis using an automated R package","volume":"58","author":"Liu","year":"2023","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.ejogrb.2024.09.040_b0045","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"Cochrane bias methods group; cochrane statistical methods group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2024.09.040_b0050","doi-asserted-by":"crossref","first-page":"e1080","DOI":"10.1002\/cl2.1080","article-title":"CINeMA: Software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell System. Rev."},{"key":"10.1016\/j.ejogrb.2024.09.040_b0055","unstructured":"van Valkenhoef Gert, Kuiper Joel. Network meta-analysis using Bayesian methods.Package: gemtc. Version: 1.0-2.2023."},{"issue":"1","key":"10.1016\/j.ejogrb.2024.09.040_b0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1167","article-title":"Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis","volume":"7","author":"van Valkenhoef","year":"2016","journal-title":"Res Synth Methods"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.09.040_b0065","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/biostatistics\/kxp032","article-title":"Modeling between-trial variance structure in mixed treatment comparisons","volume":"10","author":"Lu","year":"2009","journal-title":"Biostatistics"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.09.040_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v106.i02","article-title":"netmeta: An R package for network meta-analysis using frequentist methods","volume":"106","author":"Balduzzi","year":"2023","journal-title":"J Stat Softw"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.09.040_b0075","first-page":"176","article-title":"Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment","volume":"54","author":"Davidson","year":"1978","journal-title":"Br J Vener Dis"},{"issue":"23","key":"10.1016\/j.ejogrb.2024.09.040_b0080","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJM198612043152305","article-title":"Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy","volume":"315","author":"Sobel","year":"1986","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.09.040_b0085","first-page":"335","article-title":"Intermittent local prophylaxis against recurrent vaginal candidosis","volume":"64","author":"Bushell","year":"1988","journal-title":"Genitourin Med"},{"issue":"3 Pt 1","key":"10.1016\/j.ejogrb.2024.09.040_b0090","first-page":"330","article-title":"Clotrimazole treatment of recurrent and chronic candida vulvovaginitis","volume":"73","author":"Sobel","year":"1989","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.09.040_b0095","first-page":"357","article-title":"Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet","volume":"66","author":"Roth","year":"1990","journal-title":"Genitourin Med"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.09.040_b0100","first-page":"374","article-title":"The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis","volume":"68","author":"Fong","year":"1992","journal-title":"Genitourin Med"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.09.040_b0105","first-page":"83","article-title":"Managing recurrent vulvovaginal candidiasis. Intermittent prevention with itraconazole","volume":"42","author":"Spinillo","year":"1997","journal-title":"J Reprod Med"},{"issue":"10","key":"10.1016\/j.ejogrb.2024.09.040_b0110","first-page":"366","article-title":"Treatment of recurring vulvo-vaginal candidiasis: a comparative prospective study during six months of three anti-mycotic preparations of a single dosis","volume":"27","author":"L\u00f3pez-Olmos","year":"2000","journal-title":"Clin Invest Ginecol Obstet"},{"issue":"9","key":"10.1016\/j.ejogrb.2024.09.040_b0115","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa033114","article-title":"Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis","volume":"351","author":"Sobel","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.09.040_b0120","first-page":"307","article-title":"Effectiveness of fuconazole for suppressive maintenance therapy in patients with RVVC: a randomized placebo-controlled study","volume":"8","author":"Bolouri","year":"2009","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.ejogrb.2024.09.040_b0125","first-page":"17","article-title":"Vaginal azoles versus oral fluconazole in treatment of recurrent vulvovaginal candidiasis","volume":"2","author":"Fardyazar","year":"2007","journal-title":"Iran J Clin Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.ejogrb.2024.09.040_b0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11046-014-9827-4","article-title":"Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis","volume":"179","author":"Fan","year":"2015","journal-title":"Mycopathologia"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.09.040_b0135","doi-asserted-by":"crossref","first-page":"624.e1","DOI":"10.1016\/j.ajog.2018.03.001","article-title":"A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis","volume":"218","author":"Brand","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.09.040_b0140","unstructured":"A Study of Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) (VIOLET) ClinicalTrials.gov ID NCT03562156-."},{"key":"10.1016\/j.ejogrb.2024.09.040_b0145","unstructured":"A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) (VIOLET) ClinicalTrials.gov ID NCT03561701."},{"key":"10.1016\/j.ejogrb.2024.09.040_b0150","unstructured":"Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC) (CANDLE) ClinicalTrials.gov ID NCT04029116."},{"key":"10.1016\/j.ejogrb.2024.09.040_b0155","unstructured":"Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections (ultraVIOLET). ClinicalTrials.gov ID NCT03840616."},{"issue":"1","key":"10.1016\/j.ejogrb.2024.09.040_b0160","article-title":"Treatment for recurrent vulvovaginal candidiasis (thrush)","volume":"1","author":"Cooke","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.ejogrb.2024.09.040_b0165","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/14787210.2023.2233696","article-title":"Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)","volume":"21","author":"Vandecruys","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.09.040_b0170","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11046-023-00759-5","article-title":"The role of novel antifungals in the management of candidiasis: A clinical perspective","volume":"188","author":"Ordaya","year":"2023","journal-title":"Mycopathologia"},{"key":"10.1016\/j.ejogrb.2024.09.040_b0175","unstructured":"European Medicines Agency. Assessment report .Vivjoa International non-proprietary name: Oteseconazole. Procedure No. EMEA\/H\/C\/005682\/0000. 25 May 2023. EMA\/428048\/2023."}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524005347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524005347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T05:33:57Z","timestamp":1742016837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211524005347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":35,"alternative-id":["S0301211524005347"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.09.040","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maintenance pharmacological therapy of recurrent vulvovaginal candidiasis. A Bayesian network meta-analysis of randomized studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.09.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}